LCNB Corp’s Colgate-Palmolive CL Stock Holding History

LCNB Corp’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Buy	+2,245	New	+$196K	0.06%	182
2025 Q3	–	Sell	-2,245	Closed	-$204K	–	181
2025 Q2	$204K	Buy	+2,245	New	+$205K	0.07%	181

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

LCNB Corp's CL Position: Q2 2026 in Review

LCNB Corp opened a new position in Colgate-Palmolive (CL) in Q2 2026: 2,245 shares worth $206K. The stake represents 0.06% of the portfolio and ranks #182 among its holdings. This is a return to the name: LCNB Corp previously reported a position in CL as recently as Q2 2025.

LCNB Corp first reported a position in CL in Q2 2025 and has held it in 2 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

LCNB Corp held 2,245 shares of Colgate-Palmolive worth $206K as of Q2 2026.
Colgate-Palmolive was a new LCNB Corp position in Q2 2026.
Colgate-Palmolive made up 0.06% of LCNB Corp's portfolio in Q2 2026, its #182 holding.
LCNB Corp first reported a position in Colgate-Palmolive in Q2 2025 and has held it in 2 quarters since.
2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on LCNB Corp's 13F filing for Q2 2026, filed 10 Aug 2026.